Radiotherapy is commonly used for treating cancer by using high radiation doses for killing various cancer cells and shrinking tumors. Cancer is one of the leading life-threatening diseases across the world. The surge in the number of people suffering from cancer has always been the major driving factor for the radiation therapy market. For instance, as per the world health organization, cancer is the second leading cause of death all over the globe and was responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths are due to cancer. Approximately 70% of deaths from cancer occur in low and middle-income countries.
The
Radiotherapy Market
is expected to grow at a steady rate of around 6% during the forecast period. Factors such as increasing
government initiatives to raise awareness regarding the treatment options
available and growing demand for sophisticated therapies to cure diseases like
cancer are some of the prominent factors contributing to the growth of the
market.
Unlock The Table of Content, And Request a
Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=28907
Based on application, the radiotherapy market is classified into prostate
cancer, breast cancer, lung cancer, cervical cancer, spine cancer, head &
neck cancer, and others. In 2020, the breast cancer segment grabbed a
considerable market share, and it is expected to grow at a significant CAGR during
the forecast period owing to the rise in incidences of this type of cancer. For
instance, according to the World Health Organization, in 2020, nearly 2.26
million cases of breast cancer alone.
Based on the end-users,
the market is fragmented into
hospitals, radiation therapy centers, and others. In 2020, the hospital segment
grabbed a considerable market share, and it is expected to grow at a
significant CAGR during the forecast period. The growth of this segment is attributed
to the growing number of private hospitals in various emerging economies and
better accessibility of healthcare services at hospitals leading to a rise in
the preference of patients to avail treatment in hospitals.
Unlock The Table of Content, And Request a
Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=28907
North America to witness extensive growth
For a better understanding of the market
adoption of the radiotherapy industry, the market is analyzed based on its
worldwide presence in the countries such as North America (U.S., Canada, Rest
of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of
Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of
World. North America is anticipated to grow at a substantial CAGR during the
forecast period. The major factors such as favorable government initiatives, increased
investments in research and development for radiotherapy coupled with
technological advancements, the rapid increase in the geriatric population, and
the rising number of cancer incidences are propelling the growth of this market
in the region. For instance, the number of Americans aged 60 and older
increased by 34% from 55.7 million to 74.6 million between 2009 and 2019.
For More Informative Information, Please Visit
Us – https://univdatos.com/report/radiotherapy-market/
According to UnivDatos Market Insights (UMI)’,
the key players with a considerable market share in the Radiotherapy market are
Siemens Healthineers AG, Accuray Incorporated, Elekta AB, Becton,
Dickinson and Company, ViewRay Technologies Inc., Hitachi Ltd., IsoRay Inc., ZEISS
Group, Mevion Medical Systems Inc., Panacea Medical Technologies Pvt. Ltd.
“Global
Radiotherapy
Market” provides comprehensive qualitative and quantitative insights on
the industry potential, key factors impacting sales and purchase decisions,
hotspots, and opportunities available for the market players. Moreover, the
report also encompasses the key strategic imperatives for success for
competitors along with strategic factorial indexing measuring competitors’
capabilities on different parameters. This will help companies in the
formulation of go-to-market strategies and identifying the blue ocean for its
offerings.
Market Segmentation:
1. By
Technology (External Beam Radiotherapy, Internal Beam
Radiotherapy, and Systemic Radiotherapy)
2. By
Application (Prostate Cancer, Breast Cancer, Lung Cancer,
Cervical Cancer, Spine Cancer, Head & Neck Cancer, and Others)
3. By
End-Users (Hospitals, Radiation Therapy Centers, and
Others)
4. By
Region (North America, Europe, Asia-Pacific, Rest of
the World)
5. By
Company (Siemens Healthineers AG, Accuray
Incorporated, Elekta AB, Becton, Dickinson and Company, ViewRay Technologies
Inc., Hitachi Ltd., IsoRay Inc., ZEISS Group, Mevion Medical Systems Inc.,
Panacea Medical Technologies Pvt. Ltd.)
Key
questions answered in the study:
1.
What are the current and future trends
of the global radiotherapy industry?
2.
How the industry has been evolving in
terms of technology, application, and end-users?
3.
How the competition has been shaping
across the countries followed by their comparative factorial indexing?
4.
What are the key growth drivers and
challenges for the global radiotherapy industry?
5.
What is the customer orientation,
purchase behavior, and expectations from the global radiotherapy suppliers
across various region and countries?
Comments